Bio-Connect

Search results: p53 TP53

121 to 132 of 17.159 products
Sort by
Figure 2. Western blot analysis of extract from HT29 and Hela cells untreated or treated with UV using p53 antibody (phospho-Ser6)
Product group Antibodies
OriGene
ApplicationsWestern Blot, ImmunoHistoChemistry
ReactivityHuman, Mouse
TargetTP53
  • SizePrice
Figure 1. Western blot analysis of extract from HT-29 cells untreated or treated with UV (20 min), using p53 antibody AP08045PU (Lane 1 and 2) and p53 (pSer6) antibody AP08001PU-S (Lane 3 and 4).
Product group Antibodies
OriGene
ApplicationsWestern Blot, ImmunoHistoChemistry
ReactivityHuman, Mouse
TargetTP53
  • SizePrice
Figure 2. Western blot analysis of extract from HT-29 cells untreated or treated with hydroxyurea using p53 antibody AP08047PU (Lane 1 and 2) and p53 (pThr18) antibody AP08002PU (Lane 3 and 4).
Product group Antibodies
OriGene
ApplicationsWestern Blot
ReactivityHuman
TargetTP53
  • SizePrice
Figure 2. Western blot analysis of extract from HT-29 cells untreated or treated with hydroxyurea using p53 antibody AP08047PU (Lane 1 and 2) and p53 (pThr18) antibody AP08002PU (Lane 3 and 4).
Product group Antibodies
OriGene
ApplicationsWestern Blot
ReactivityHuman
TargetTP53
  • SizePrice
Figure 1. Western blot analysis of extract from HT-29 cells untreated or treated with UV (20 min), using p53 antibody (Lane 1 and 2) and p53 pSer33 antibody (Lane 3 and 4).
Product group Antibodies
OriGene
ApplicationsImmunoFluorescence, Western Blot
ReactivityHuman
TargetTP53
  • SizePrice
Figure 1. Western blot analysis of extract from HT-29 cells untreated or treated with UV (20 min), using p53 antibody (Lane 1 and 2) and p53 pSer33 antibody (Lane 3 and 4).
Product group Antibodies
OriGene
ApplicationsImmunoFluorescence, Western Blot
ReactivityHuman
TargetTP53
  • SizePrice
Figure 1. Western blot analysis of extract from HT-29 cells untreated or treated with Doxorubicin (1mM, 30min), using p53 antibody (Lane 1 and 2) and p53 pSer37 antibody (Lane 3 and 4).
Product group Antibodies
OriGene
ApplicationsImmunoFluorescence, Western Blot
ReactivityHuman
TargetTP53
  • SizePrice
Figure 1. Western blot analysis of extract from HT-29 cells untreated or treated with Doxorubicin (1mM, 30min), using p53 antibody (Lane 1 and 2) and p53 pSer37 antibody (Lane 3 and 4).
Product group Antibodies
OriGene
ApplicationsImmunoFluorescence, Western Blot
ReactivityHuman
TargetTP53
  • SizePrice
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using p53 (Phospho-Thr387) antibody (left)or the same antibody preincubated with blocking peptide (right).
Product group Antibodies
OriGene
ApplicationsImmunoHistoChemistry
ReactivityHuman
TargetTP53
  • SizePrice
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using p53 (Phospho-Thr387) Antibody (left)or the same antibody preincubated with blocking peptide (right).
Product group Antibodies
OriGene
ApplicationsImmunoHistoChemistry
ReactivityHuman
TargetTP53
  • SizePrice
Dot blot analysis of anti-p53 pThr55 Pab (Cat#AP12907PU-N) on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.5ug per ml.
Product group Antibodies
OriGene
ReactivityHuman
TargetTP53
  • SizePrice
p53 antibody staining of Formalin-Fixed, Paraffin-Embedded Human cancer tissue using peroxidase-conjugate and AEC chromogen.
Product group Antibodies
OriGene
ApplicationsWestern Blot, ImmunoHistoChemistry
ReactivityHuman
TargetTP53
  • SizePrice